GNC Debuts New Section Dedicated to Supporting GLP-1 Patients
Retail TouchPoints
APRIL 29, 2024
Health retailer GNC has debuted a new store section , dedicated to helping individuals who are using GLP-1 medications like Ozempic to mitigate and manage the side effects of the powerful weight loss drugs. The new section will be featured in all of the retailer’s 2,300+ U.S. locations. As many as 130 million Americans currently live with a condition that could be treated with a GLP-1 agonist, and as many as 70 million Americans could be using the medication by 2028 , according to some estimates
Let's personalize your content